| Company Name: |
Beijing Comparison Pharmaceutical Technology Co., Ltd
|
| Tel: |
010-010-52878169 15801002657 |
| Email: |
sales@bjcomparison.com |
| Products Intro: |
Product Name:(3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate
CAS:1428118-12-0
Purity:99.97% Package:100mg;50mg;25mg;10mg Remarks:ATG049-34
|
|
| | (3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate Basic information |
| Product Name: | (3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate | | Synonyms: | Atorvastatin impurity 24/(3S,5S)-Atorvastatin tert-Butyl Ester/(3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate;1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, 1,1-dimethylethyl ester, (βS,δS)-;(βS,δS)-Atorvastatin tert-Butyl Ester;1H-?Pyrrole-?1-?heptanoic acid, 2-?(4-?fluorophenyl)?-?β,?δ-?dihydroxy-?5-?(1-?methylethyl)?-?3-?phenyl-?4-?[(phenylamino)?carbonyl]?-?, 1,?1-?dimethylethyl ester, (βS,?δS)?-;(3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate;Atorvastatin Calcium Hydrate impurity 34;Atorvastatin calcium-25;Atorvastatin calcium impurity 34 | | CAS: | 1428118-12-0 | | MF: | C37H43FN2O5 | | MW: | 614.75 | | EINECS: | | | Product Categories: | | | Mol File: | 1428118-12-0.mol |  |
| | (3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate Chemical Properties |
| | (3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate Usage And Synthesis |
| Uses | (βS,δS)-Atorvastatin tert-Butyl Ester is an intermediate used in the synthesis of (3S,5S)-Atorvastatin Sodium Salt (A791735), which is a selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia. |
| | (3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate Preparation Products And Raw materials |
|